← Open Payments lookup

ADRIANA ACOSTA: Open Payments

NPI 1871693986 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,459 in 112 payments from 16 companies in 2025. Trend: 2023 $2,514 · 2024 $2,228 · 2025 $2,459

Food & beverage: $2,459
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$408
ABBVIE INC.32$400
GENZYME CORPORATION10$349
Janssen Biotech, Inc.11$255
Ardelyx, Inc.11$247
Ethicon US, LLC1$136
Takeda Pharmaceuticals U.S.A., Inc.5$103
Gilead Sciences, Inc.4$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$101
Aimmune Therapeutics, Inc.5$96

Products named: REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, RINVOQ, EVARREST, LINZESS, XIFAXAN.

Industry payments across FL — which companies pay providers there.